Egg Cartel Exploitation: How Major Corporations are Capitalizing on Avian Flu to Inflate Prices and Profits

In Washington, DC, a recent analysis suggests that major egg corporations may be exploiting the avian flu outbreak as a means to inflate prices, resulting in soaring profits at the expense of American consumers. The cost of a dozen large eggs skyrocketed to nearly $5 in January, marking a significant increase from the average price three years ago before the outbreak. This surge in prices has impacted many American families who rely on eggs as an affordable source of protein.

While avian flu has been identified as a key factor behind the rising egg prices, new research indicates that the highly concentrated egg market may also be contributing to the escalating costs. According to the analysis conducted by Food and Water Watch, powerful corporations controlling all stages of the egg supply chain are capitalizing on the crisis to generate substantial profits, surpassing what is necessary to cover any increased expenses.

The study revealed that in certain regions, egg prices were on the rise even before the new strain of the H5N1 virus affected poultry flocks and reduced egg production. Despite an increase in egg production in 2022 and 2023 compared to previous years, retail prices continued to climb. This disparity between production levels and consumer prices has raised concerns about potential price gouging in the industry.

One of the largest egg producers in the country, Cal-Maine, reported a significant increase in gross profits in fiscal year 2023, despite not experiencing any avian flu outbreaks in its flocks during that period. The company’s substantial profit margins have sparked questions about the transparency and fairness of the pricing practices within the egg industry.

The analysis also highlighted the impact of the avian flu outbreak on retail prices, with consumer prices surging by 61% over the past six months. The economic repercussions of losing hen flocks due to the virus have contributed to a notable increase in retail prices, further straining the budgets of American households.

As concerns about the rising cost of eggs continue to grow, federal antitrust agencies have been urged to investigate potential collusion among major egg producers. The lack of publicly accessible financial records for other industry players has raised suspicions about anti-competitive practices influencing price hikes in the market.

Although consumers are feeling the pinch of escalating egg prices, there is no definitive evidence of collusion among industry players. However, the concentrated nature of the egg production industry has led to questions about market manipulation and unfair pricing practices, prompting calls for regulatory scrutiny and oversight.

In response to the mounting pressure to address soaring egg prices, the Trump administration has outlined a strategy to lower costs by investing in curbing the avian flu outbreak and exploring new vaccination and biosecurity measures. The administration’s efforts to address the root causes of the price hikes aim to alleviate the financial burden on American consumers and ensure greater transparency and accountability in the egg industry.